National Health Investors, Inc. (NYSE:NHI) Announces Quarterly Dividend of $0.90

National Health Investors, Inc. (NYSE:NHI) announced a quarterly dividend on Tuesday, November 5th, Wall Street Journal reports. Shareholders of record on Tuesday, December 31st will be paid a dividend of 0.90 per share by the real estate investment trust on Wednesday, January 29th. This represents a $3.60 dividend on an annualized basis and a yield of 4.69%. The ex-dividend date is Tuesday, December 31st.

National Health Investors has raised its dividend by an average of 0.9% per year over the last three years. National Health Investors has a payout ratio of 115.0% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities research analysts expect National Health Investors to earn $4.66 per share next year, which means the company should continue to be able to cover its $3.60 annual dividend with an expected future payout ratio of 77.3%.

National Health Investors Stock Performance

Shares of NYSE:NHI opened at $76.76 on Thursday. The business’s fifty day moving average price is $80.38 and its two-hundred day moving average price is $73.16. National Health Investors has a fifty-two week low of $49.25 and a fifty-two week high of $86.13. The stock has a market capitalization of $3.34 billion, a price-to-earnings ratio of 26.11, a price-to-earnings-growth ratio of 5.05 and a beta of 1.05. The company has a debt-to-equity ratio of 0.91, a current ratio of 10.27 and a quick ratio of 10.27.

National Health Investors (NYSE:NHI) last announced its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The business had revenue of $63.32 million for the quarter, compared to the consensus estimate of $67.93 million. During the same quarter in the previous year, the company posted $1.08 EPS. National Health Investors’s revenue for the quarter was up 1.7% on a year-over-year basis. As a group, analysts predict that National Health Investors will post 4.48 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

NHI has been the subject of a number of research reports. StockNews.com lowered National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Truist Financial raised their target price on National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research note on Friday, August 30th. Bank of America initiated coverage on National Health Investors in a research note on Tuesday, September 24th. They issued a “buy” rating and a $92.00 target price for the company. Finally, Wells Fargo & Company lowered National Health Investors from an “overweight” rating to an “equal weight” rating and raised their target price for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $73.29.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.